Trial Profile
Determinants of Vaccine Response to Influenza Vaccination Among Individuals Over 65 Years of Age - a Population-based Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2019
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 09 Dec 2019 According to a Seqirus media release, findings from the trial were presented at the recent National Foundation for Infectious Diseases (NFID) 2019 Clinical Vaccinology Course (CVC) held at Washington, D.C.
- 09 Dec 2019 Results presented in the Seqirus media release.
- 08 Sep 2017 Status changed from not yet recruiting to completed.